Process evaluation of a bio-behavioural HIV research combined with prevention among GBMSM in 13 European countries.


Journal

Global public health
ISSN: 1744-1706
Titre abrégé: Glob Public Health
Pays: England
ID NLM: 101256323

Informations de publication

Date de publication:
05 2022
Historique:
pubmed: 19 1 2021
medline: 28 4 2022
entrez: 18 1 2021
Statut: ppublish

Résumé

Comparative European data using Second Generation Surveillance System (SGSS) are scarce among gay, bisexual and other men who have sex with men. This study evaluated the implementation of Sialon II, a bio-behavioural HIV research combined with targeted HIV prevention in 13 European cities conducted in collaboration with community partners. A mixed-methods process evaluation assessed the project's coverage, outputs, quality, challenges and opportunities for improvement. Data collected through structured questionnaire from 71 data collectors from community-based organisations and semi-structured interviews with 17 managers of participating gay venues were analysed. Overall implementation was successful, achieving 4901 valid behavioural questionnaires and obtaining 4716 biological samples. Challenges in conducting bio-behavioural research in gay venues related to strict research protocols and unfavourable characteristics of venues. Formative research, collaboration with community gay venues, and offering HIV prevention emerged as facilitators. Community researchers' training was crucial for fidelity to research protocols, increased trust amongst communities and enabled data collectors to effectively address practical problems in the field. Scientifically sound SGSS with community participation is feasible and allows for including 'hard-to-reach' populations. Prevention benefits include awareness raising, capacity building and sexual health promotion in gay venues. The findings are beneficial for epidemiological research among other HIV key populations.

Identifiants

pubmed: 33460361
doi: 10.1080/17441692.2021.1874469
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

672-687

Auteurs

Sónia Dias (S)

NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisboa, Portugal.
Comprehensive Health Research Centre (CHRC), Lisboa, Portugal.

Ana Gama (A)

NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisboa, Portugal.
Comprehensive Health Research Centre (CHRC), Lisboa, Portugal.

Nigel Sherriff (N)

School of Health Sciences, University of Brighton, Brighton, UK.

Lorenzo Gios (L)

Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Wim Vanden Berghe (WV)

Epidemiology of Infectious Diseases, Sciensano, Brussels, Belgium.

Cinta Folch (C)

Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Dept Salut, Generalitat de Catalunya/CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain.

Ulrich Marcus (U)

Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Danica Valkovičová Staneková (DV)

NRC for HIV/AIDS, Slovak Medical University, Bratislava, Slovak Republic.

Michał Pawlęga (M)

Social AIDS Committee, Warsaw, Poland.

Saulius Caplinskas (S)

Centre for Communicable Diseases and AIDS, Mykolas Romeris University, Vilnius, Lithuania.

Emilia Naseva (E)

Ministry of Health, Program "Prevention and Control of HIV/AIDS", Sofia, Bulgaria.

Irena Klavs (I)

National Institute of Public Health, Ljubljana, Slovenia.

Inga Velicko (I)

Public Health Agency of Sweden, Stockholm, Sweden.

Massimo Mirandola (M)

Epidemiology Unit - UOC Infectious Diseases, Verona University Hospital, Verona, Italy.

Christiana Nöstlinger (C)

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH